Kabra Drugs Ltd.
| BSE: 524322 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE323K01017 |
| BSE 00:00 | 03 Feb | 4.83 |
0.23 (5.00%) |
OPEN
4.83 |
HIGH
4.83 |
LOW
4.83 |
| NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
| OPEN | 4.83 |
| PREVIOUS CLOSE | 4.60 |
| VOLUME | 298 |
| 52-Week high | 5.70 |
| 52-Week low | 2.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kabra Drugs Ltd. (KABRADRUGS) - Company Information
Kabra Drugs Ltd
Kabra Drugs Ltd was incorporated on August 22 1989 as a Private Limited Company. Subsequently the company was converted into a Public Limited Company on April 1 1992. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia) Solvent Ether Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 199...> More
| COMPANY INFORMATION | |||||||
| Whole Time Director & CFO : | B V Anatha Kumar | ||||||
| Independent Director : | Ananthkumar Shilpa | ||||||
| Independent Director : | Churchil Durai M Jebastine | ||||||
| Independent Director : | KUNIAMUTHUR NANJAPPAN ANAND | ||||||
| Company Sec. & Compli. Officer : | Monika Sanwal | ||||||
| Independent Director : | A Anitha | ||||||
| AUDITOR : | Rishi Sekhri & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 270 Shastri Market Indore, ,Indore,Madhya Pradesh-452007 | |||||||
| Ph : | |||||||
| WEBSITE : http://www.kabradrugslimited.com | |||||||
| E-mail : kabradrugs@rediffmail.com | |||||||
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
